Harness the power of catalytic continuous flow reactions to achieve safer, greener, and more efficient chemical manufacturing with enhanced scalability and product quality.
ABOUT SK PHARMTECO
At SK pharmteco our mission is to build strong relationships that create happiness for our customers through the shared goal of producing and delivering life-changing therapies that improve patient outcomes and save lives. With our network of seven global, cutting-edge, facilities our capabilities cover the entire product lifecycle, from initial development to commercial manufacturing. We work with customers in a flexible ‘One Team’ approach, prioritizing collaboration, transparency, and trust to make every interaction easy and seamless.
SK pharmteco offers CDMO services for small molecule, Gene therapy, and Analytical testing, contact our experts to learn more!
CONTACT INFORMATION
SK pharmteco
12460 Akron St #100
Rancho Cordova, CA 95742
Contact: Liza Rivera
SMALL MOLECULE
-
Scaling Complex Science With Flexibility And Reliability
Discover a global CDMO that provides flexible small molecule development, manufacturing, and analytical services to accelerate drug commercialization and improve efficiency.
-
Addressing The Acetonitrile Supply By Implementing Strategies
Rising acetonitrile demand threatens supply chains; recovery and reuse methods using evaporation and crystallization produce high‑purity solvent, reducing costs, waste, and reliance on fresh supply.
-
SK Pharmteco Capabilities Update March 2026: Small Molecule Drug Substance
Join Frank Mueller, Executive Director of Business Development, for an overview of our capabilities and global capacity spanning North America, Europe, and Asia.
-
Spray Drying Applications In The Pharmaceutical Industry
Spray drying turns liquids into uniform powders, improving stability, solubility, flowability, and bioavailability while allowing precise control of particle traits.
-
Chromatography That Conquers Complexity
Supported by specialized containment infrastructure and deep HPAPI expertise, our chromatography capabilities ensure safe handling of highly potent compounds while delivering consistent, high-quality purification outcomes.
-
Advancing ADCs With Expertise In Payloads And Linkers
Discover how integrated containment, high-potency expertise, advanced chromatography, and proven linker–payload process optimization can accelerate your ADC program from early development to reliable commercial supply.
-
Supporting Your ADCs With Proven Payload And Linker Manufacturing
From gram-scale quantities for early-phase studies to multi-kilogram commercial supply, our facilities and technical teams are equipped to deliver safe, efficient, and compliant solutions.
-
Synthetic Peptide Solutions That Keep Your Program Moving
Leverage scalable hybrid SPPS/LPPS manufacturing strategies and deep small-molecule expertise to efficiently advance peptide programs from development through multi-ton commercial production.
-
Advancing Drug Development Through Expertise In Energetic Chemistry
Overcoming development complexity requires robust process safety. Solutions can safely scale challenging reactions, like click chemistry and cryogenic organometallics, improving efficiency and results.
CELL & GENE THERAPY
-
SK Pharmteco Capabilities Update July 2026: Gene Therapy
Adaptive viral vector platforms pair scalable manufacturing with targeted purification. Customizing workflows ensures high vector purity and cost efficiency, accelerating clinical development.
-
Solving Challenges For Vectors That Are Complex In Practice
Overcome adenoviral scale-up challenges with a design-to-scale manufacturing framework that optimizes cell growth, boosts vector productivity, and supports reliable clinical supply.
-
Maximizing Efficiency In Lentiviral Vector Manufacturing
Accelerate cell and gene therapy programs with scalable lentiviral vector manufacturing, delivering high titers, exceptional purity, and reliable clinical supply from gene to clinic.
-
Optimizing Adenoviral Production With Adaptive Process Architecture
Speed adenoviral vector development with scalable suspension processes and hybrid purification workflows that improve yield, efficiency, and clinical readiness.
-
Advancing AAV Therapies From Concept To Commercial Supply
Accelerate gene therapy development with a scalable AAV platform delivering high yield, reproducibility, integrated analytics, and reliable clinical supply from design to production.
-
Viral Vector Solutions That Move Your Program Forward
Optimize your viral vector program with scalable manufacturing, advanced process development, regulatory-ready workflows, and integrated fill-finish solutions to accelerate market success.
-
A Rapid, Scalable Lentiviral Vector Purification Platform
Integrated capture and polishing reduce upstream impurities, enabling high‑capacity polishing, strong lentiviral recovery, and scalable purity for downstream in vivo applications.
-
Accelerated Yield Optimization Of Affinity Capture
High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.
-
Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery
Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.
-
Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies
Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.
CONTRACTS & ANALYTICAL
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
The Evolving Landscape Of HPAPI Contract Manufacturing
Surging demand for highly potent drugs is driven by targeted therapies, stricter containment standards, increased outsourcing, and the need for specialized, compliant manufacturing.
-
Biocatalysis 101: Faster, Greener API Manufacturing
View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
Green Chemistry: Real-Time Analysis For Pollution Prevention
Gaining real-time visibility into chemical processes helps stop hazardous substance formation. Process monitoring reduces waste, cuts down on reagent use, and optimizes reaction time.
-
The Principles Of Green Chemistry: Design For Degradation
Designing chemicals to degrade safely reduces environmental risk. Balancing business needs with planned degradation, starting in the early design phase, ensures a sustainable lifecycle for new molecules.
-
The Principles Of Green Chemistry: Reduce Derivatives
Design synthetic routes to minimize or eliminate unnecessary temporary blocking groups. This reduces reagent use, yield loss, and waste generation, improving overall process efficiency.
-
The Principles Of Green Chemistry: Use Of Renewable Feedstocks
Adopting renewable feedstocks is crucial for green chemistry. Innovations using bio-renewable materials can drastically reduce waste, solvent use, and process steps, leading to major benefits.
-
A Review Of The Twelve Principles Of Green Chemistry
Prevention and design are foundational to green chemistry, requiring foresight to minimize hazards from the start. Reducing reliance on solvents is a critical step toward sustainability.
-
The Principles Of Green Chemistry: Safer Solvents And Auxiliaries
Solvents account for the majority of the environmental impact in chemical synthesis. Consider adopting safer alternatives and implementing reuse strategies to reduce waste, emissions, and toxicity.
-
High Potency Active Pharmaceutical Ingredients
Safely manufacturing HPAPIs and cytotoxic compounds requires specialized expertise and purpose-built facilities. Discover solutions from process development to commercial scale, including for ADC payloads.